High-dose antipsychotic therapy: does it have a role?

A high proportion of people prescribed antipsychotic polypharmacy are also taking high-dose antipsychotic therapy.

Loneliness and the pharmacist advocate

Enforced isolation due to the COVID-19 pandemic has significantly increased the level of loneliness in Australia.

Pharmacists have skills to help with COVID-19 vaccine roll-out

The range of vaccines trained pharmacist immunisers can administer should be expanded in order to protect the community, PSA has argued in its 2021–22 Pre-Budget Submission to the Victorian Government.

Podcast: allergic rhinitis and children

Despite being the most prevalent allergic disorder in Australia and New Zealand, allergic rhinitis is often underdiagnosed and undertreated.

How pharmacists can support people with eating disorders

Eating disorders (EDs) are an area of focus in the Federal Government’s Long Term National Health Plan. But how common are they and what...

COVID-19: Finish line or first lap?

As Australia reaches vaccine targets, what’s next for pharmacists and Australians?